Coronary and peripheral blood flow changes following biventricular pacing and their relation to heart failure improvement

Europace

Volumn 8, Issue 1, 2006, Pages 44-50

  Flevari, Panayota ^a   Theodorakis, George ^a   Paraskevaidis, Ioannis ^a   Kolokathis, Fotis ^a   Kostopoulou, Anna ^a   Leftheriotis, Dionyssios ^a   Kroupis, Christos ^a   Livanis, Efthimios ^a   Kremastinos, Dimitrios T ^a  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

Author keywords

Blood flow; Heart failure; Pacing

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOCHEMICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CELL ADHESION MOLECULE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; SPIRONOLACTONE; VASCULAR CELL ADHESION MOLECULE 1; BIOLOGICAL MARKER; INTERCELLULAR ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DEFIBRILLATION; DISEASE CLASSIFICATION; EXERCISE; FEMALE; FOREARM BLOOD FLOW; FUNCTIONAL STATUS; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPEREMIA; MALE; MEDICAL ASSESSMENT; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; PROGNOSIS; QRS COMPLEX; REST; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT OUTCOME; VEIN OCCLUSION PLETHYSMOGRAPHY; ANALYSIS OF VARIANCE; BLOOD; BLOOD FLOW VELOCITY; CONGESTIVE HEART FAILURE; ECHOCARDIOGRAPHY; ECHOGRAPHY; EXERCISE TEST; FOREARM; HEART PACING; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PLETHYSMOGRAPHY; STATISTICAL MODEL; VASCULARIZATION;

AGED; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BLOOD FLOW VELOCITY; CARDIAC PACING, ARTIFICIAL; CORONARY CIRCULATION; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; FOREARM; HEART FAILURE, CONGESTIVE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LINEAR MODELS; MALE; NATRIURETIC PEPTIDE, BRAIN; OXYGEN CONSUMPTION; PLETHYSMOGRAPHY; PROGNOSIS; TREATMENT OUTCOME; VASCULAR CELL ADHESION MOLECULE-1;

EID: 33745228415     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euj015     Document Type: Article

References (40)

1. Ukkonen H, Beanlands RS, Burwash IG et al. Effect of cardiac resynchronization on myocardial efficiency and regional oxidative metabolism. Circulation 2003;107:28-31.
2. Nelson GS, Berger RD, Fetics BJ et al. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopahy and left bundle-branch block. Circulation 2000;102:3053-3059.
3. Bradley DJ, Bradley EA, Baughman KL et al. Cardiac resynchronization and death from progressive heart failure: A meta-analysis of randomized controlled trials. JAMA 2003;289:730-740.
4. Leclercq C, Kass DA. Retiming the failing heart: Principles and current clinical status of cardiac resynchronization. J Am Coll Cardiol 2002;39:194-201.
5. Auricchio A, Stellbrink C, Sack S et al. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002;39:2026-2033.
6. Linde C, Leclercq C, Rex S et al. Long-term benefits of biventricular pacing in congestive heart failure: Results from the Multisite STImulation in Cardiomyopathy (MUSTIC) study. J Am Coll Cardiol 2002;40:111-118.
7. Abraham WT, Fisher WG, Smith AL et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-1853.
8. Camici PG, Rimoldi OE. Myocardial blood flow in patients with hibernating myocardium. Cardiovasc Res 2003;57:302-311.
9. Neglia D, Michelassi C, Trivieri MG et al. Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation 2002;105:186-193.
10. Baumgart D, Haude M, Liu F, Ge J, Goerge G, Erbel R. Currents concepts of coronary flow reserve for clinical decision making during cardiac catheterization. Am Heart J 1998;136:136-149.
11. Iliceto S, Marangelli V, Memmola C, Rizzon P. Transesophageal Doppler echocardiography evaluation of coronary blood flow velocity in baseline conditions and during dipyridamole-induced coronary vasodilation. Circulation 1991;83:61-69.
12. Redberg RF, Sobol Y, Chou TM. Adenosine-induced coronary vasodilation during transesophageal Doppler echocardiography. Rapid and safe measurement of coronary flow reserve can predict significant left anterior descending coronary stenosis. Circulation 1995;92:190-196.
13. Gadallah S, Thaker KB, Kawanishi D et al. Comparison of intracoronary Doppler guide wire and transesophageal echocardiography in measurement of flow velocity and coronary flow reserve in the left anterior descending coronary artery. Am Heart J 1998;135:38-42.
14. Drexler H. Endothelium as a therapeutic target in heart failure. Circulation 1998;98:2652-2655.
15. Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Kajiyama G, Oshima T. A noninvasive measurement of reactive hyperemia that can be used to assess resistance artery endothelial function in humans. Am J Cardiol 2001;87:121-125.
16. Richards AM, Doughty R, Nicholls MG et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: Prognostic utility and prediction of benefit from carvedilol in chronic ischaemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group. J Am Coll Cardiol 2001;37:1781-1787.
17. Fisher C, Berry C, Blue L, Morton JJ, McMurray J. N-terminal pro B type natriuretic peptide, but not the new putative cardiac hormone relaxin, predicts prognosis in patients with chronic heart failure. Heart 2003; 89:879-881.
18. Tsutamoto T, Hisanaga T, Fukai D et al. Prognostic value of plasma soluble intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure. Am J Cardiol 1995; 76:803-808.
19. Yin WH, Chen JW, Jen HL et al. The prognostic value of circulating soluble cell adhesion molecules in patients with chronic congestive heart failure. Eur J Heart Fail 2003;5:507-516.
20. Gregoratos G, Abrams J, Epstein AE et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: Summary article - a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Circulation 2002;106:2145-2161.
21. Ritter P, Padaletti L, Gillio-Meina L, Gaggini G. Determination of the optimal atrioventricular delay in DDD pacing. Comparison between echo and peak endocardial acceleration measurements. Europace 1999;1:126-130.
22. Schiller NB, Shah PM, Crawford M et al. Recommendations for quantification of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989;2:358-367.
23. Paraskevaidis IA, Tsiapras D, Karavolias GK, Kyriakides ZS, Kremastinos DTh. Serial evaluation of coronary flow reserve by transesophageal Doppler echocardiography after angioplasty of proximal left anterior descending coronary artery: A 6-month follow-up study. Coron Artery Dis 2001; 12:45-52.
24. Sbarouni E, Flevari P, Kroupis C, Kyriakides ZS, Koniavitou K, Kremastinos D. The effects of raloxifene and simvastatin on plasma lipids and endothelium. Cardiovasc Drugs Ther 2003;17:319-323.
25. Tagawa T, Imaizumi T, Endo T, Shiramoto M, Harasawa Y, Takeshita A. Role of nitric oxide in reactive hyperemia in human forearm vessels. Circulation 1994;90:2285-2290.
26. Cazeau S, Leclercq C, Lavergne T et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344:873-880.
27. Nitenberg A, Fault JM, Blanchet F, Zouioueche S. Multifactorial determinants of reduced coronary flow reserve after dipyridamole in dilated cardiomyopathy. Am J Cardiol 1985;55:748-754.
28. Ono S, Nohara R, Kambara H, Okuda K, Kawai C. Regional myocardial perfusion and glucose metabolism in experimental left bundle branch block. Circulation 1992;85:1125-1131.
29. Stolen KQ, Kemppainen J, Kalliokoski KK et al. Myocardial perfusion reserve and peripheral endothelial function in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 2004;93:64-68.
30. Sundell J, Engblom E, Koistinen J et al. The effects of resynchronization therapy on left ventricular function, myocardial energetics and metabolic reserve in patients with dilated cardiomyopathy and heart failure. J Am Coll Cardiol 2004;43:1027-1033.
31. Knaapen P, Van Campen L, De Cock CC et al. Effects of cardiac resynchronization therapy on myocardial perfusion reserve. Circulation 2004; 110:646-651.
32. Rajappan K, Rimoldi OE, Dutka DP et al. Mechanisms of coronary microcirculatory dysfunction in patients with aortic stenosis and angiographically normal coronary arteries. Circulation 2002;105:470-476.
33. Kjekshus JK. Mechanism for flow distribution in normal and ischemic myocardium during increased ventricular preload in the dog. Circ Res 1973;33:489-499.
34. Lindner O, Vogt J, Kammeier A et al. Effect of cardiac resynchronization therapy on global and regional oxygen consumption and myocardial blood flow in patients with non-ischaemic and ischaemic cardiomyopathy. Eur Heart J 2005;26:70-76.
35. Hagashi Y, Yoshizumi M. New methods to evaluate endothelial function: method for assessing endothelial function in humans using a strain-gauge plethysmograph: Nitric oxide-dependent and -independent vasodilation. J Pharmacol Sci 2003;93:399-404.
36. Libby P, Sukhova G, Lee RT, Galis ZS. Cytokines regulate vascular function related to stability of the atherosclerotic plaque. J Cardiovasc Pharmacol 1995;24(Suppl. 2):9-12.
37. Tousoulis D, Antoniades C, Bosinakou E, Kotsopoulou M, Pitsavos C, Vlachopoulos C, Panagiotakos D, Stefanadis C. Effects of atorvastatin on reactive hyperemia and inflammatory process in patients with congestive heart failure. Atherosclerosis 2005;178:359-363.
38. Auricchio A, Kloss M, Trautman SI, Rodner S, Klein H. Exercise performance following cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. Am J Cardiol 2002;89:198-203.
39. Opasich C, Pinna GD, Bobbio M et al. Peak exercise oxygen consumption in chronic heart failure: Toward efficient use in the individual patient. J Am Coll Cardiol 1998;31:766-775.
40. Isnard R, Pousset F, Trocha JN et al. Prognostic value of neurohormonal activation and cardiopulmonary exercise testing in patients with chronic heart failure. Am J Cardiol 2000;86:417-421.